Showing results (2241-2250 of 22,048) with videos related to
Sort By:
Pageof 2,205
Oncogene|July 21, 2009
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic propertiesC Coulouarn, V M Factor, J B Andersen, et al.Oncogene|July 1, 1990
Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissuesM F Press, C Cordon-Cardo, D J SlamonOncogene|September 15, 2009
Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditionsD Walerych, M B Olszewski, M Gutkowska, et al.Oncogene|September 8, 2009
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.Oncogene|September 8, 2009
Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathwayA C Hoover, G L Strand, P N Nowicki, et al.Oncogene|September 8, 2009
RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cellsY Jian, Z Gao, J Sun, et al.Oncogene|September 22, 2009
Heat shock protein 27 mediates repression of androgen receptor function by protein kinase D1 in prostate cancer cellsS Hassan, M H U Biswas, C Zhang, et al.Oncogene|September 22, 2009
Lysine 269 is essential for cyclin D1 ubiquitylation by the SCF(Fbx4/alphaB-crystallin) ligase and subsequent proteasome-dependent degradationO Barbash, E Egan, L L Pontano, et al.Oncogene|March 31, 2009
Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiationR Ciarapica, D Annibali, L Raimondi, et al.Oncogene|March 31, 2009
TrkA overexpression enhances growth and metastasis of breast cancer cellsC Lagadec, S Meignan, E Adriaenssens, et al.Pageof 2,205